Client
German Biotech company making safer, effective and differentiated Novel drugs
Client Need
Innovator partners to collaborate on a new class of proteins - Anticalins® to develop various programs in Oncology and Ophthalmology.
Solution Approach
- Aagami identified right partners, and took them to 7 interested companies for Anticalins®
- With focused efforts 3 companies moved to term sheet level discussions. Aagami kept facilitating and persevering. 2 companies remained for final negotiations.
- Aagami maintained its spirits and perseverance knowing business and socio-cultural differences of various countries/regions; even when client was ready to give up as per their ways.
- Finally co development partnership happened in next few months with one company in Oncology.
- Second company took more time and couple of visits before signing co-development deal for ophthalmic therapy.
Results
- Client signed co-development deals with 2 companies in Oct and Dec 2013 respectively.
- Right companies, right advice, structure, perseverance and commitment were the key success factor. in making it happen.
- Aagami proved highly influential in negotiations for finalization of the deals due to deep experience in business culture nuances of various geographies.
- It brought repeat and referral business to Aagami.
Downloadable Version: